- Home
- ORGO vs HUYA Comparison
ORGO vs HUYA Comparison
Compare ORGO & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGO | HUYA |
|---|---|---|
| Founded | 1985 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.4M | 713.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ORGO | HUYA |
|---|---|---|
| Price | $4.80 | $3.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $8.00 | $3.50 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 79.81% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $465,218,000.00 | ★ $879,277,448.00 |
| Revenue This Year | $8.14 | $9.05 |
| Revenue Next Year | $6.33 | $11.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.24 | ★ 2.40 |
| 52 Week Low | $2.61 | $2.21 |
| 52 Week High | $7.08 | $4.59 |
Technical Indicators
Market Signals| Indicator | ORGO | HUYA |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 57.40 |
| Support Level | $4.66 | $2.75 |
| Resistance Level | $5.83 | $3.38 |
| Average True Range (ATR) | 0.20 | 0.13 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 18.13 | 55.81 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.